STERIS (STE) Stock: Charts & Financials

STERIS plc (STE)STESTERIS plc

About STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Dublin, DU

17,937 employees

www.steris.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Daniel A. Carestio

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	4.54B	1K	1.59B	1.50B	1.46B	1.39B	1.48B	1.37B	1.33B
Cost of Goods Sold	2.55B	808.60	891.30M	840.60M	814.40M	763.10M	839.32M	760.24M	750.12M
Gross Profit	2.00B	684.20	697.10M	655.50M	645.90M	628.00M	641.21M	610.33M	578.79M
Gross Profit Margin	44.0%	45.8%	43.9%	43.8%	44.2%	45.1%	43.3%	44.5%	43.6%
Total Operating Expenses	1.14B	398.30	380.60M	382.30M	380.10M	382.00M	425.06M	365.04M	359.13M
Research & Development	86.50M	28.60	28.80M	29.50M	28.20M	26.40M	27.69M	27.36M	27.03M
Selling, General & Administrative	1.05B	369.70	351.80M	352.40M	349.70M	353.80M	333.90M	335.45M	329.30M
Operating Income (EBIT)	855.80M	285.80	316.80M	271.00M	268.00M	246.00M	216.15M	245.29M	219.67M
Operating Margin	18.8%	19.1%	19.9%	18.1%	18.4%	17.7%	14.6%	17.9%	16.5%
Income Before Tax (EBT)	815.40M	273.50	304.50M	257.80M	253.10M	231.90M	197.31M	228.75M	194.89M
Interest Income	4.20M	3.10	N/A	1.80M	2.40M	1.80M	3.53M	2.43M	1.13M
Interest Expense	44.80M	15.80	15.10M	14.80M	14.90M	15.90M	17.11M	19.09M	19.67M
Other Income/Expense	-40.40M	-12.30	-12.30M	-13.20M	-14.90M	-14.10M	-18.84M	-16.55M	-24.77M
Net Income	605.00M	200.10	220.30M	192.80M	191.90M	177.40M	145.67M	173.53M	150.03M
Income Tax Expense	208.30M	72.50	84.20M	63.50M	60.60M	53.90M	50.45M	55.38M	43.51M
Net Profit Margin	13.3%	13.4%	13.9%	12.9%	13.1%	12.8%	9.8%	12.7%	11.3%
EBITDA	1.46B	285.80	677.30M	393.00M	389.70M	365.40M	338.50M	371.21M	334.92M
EBITDA Margin	32.1%	19.1%	42.6%	26.3%	26.7%	26.3%	22.9%	27.1%	25.2%
Depreciation & Amortization	604.20M	0.00	360.50M	122.00M	121.70M	119.40M	122.35M	125.91M	115.25M
EPS Basic	8.20	2.05	2.24	1.96	1.95	1.80	1.48	1.76	1.52
EPS Diluted	8.18	2.04	2.24	1.96	1.94	1.79	1.48	1.75	1.51
Shares Outstanding	98	98	98.00M	98.30M	98.40M	98.40M	98.27M	98.49M	98.67M
Diluted Shares Outstanding	98	98	98.40M	98.80M	98.80M	98.80M	98.76M	98.94M	99.20M

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Revenue

4.54B

1.59B

1.50B

1.46B

1.39B

1.48B

1.37B

1.33B

Cost of Goods Sold

2.55B

808.60

891.30M

840.60M

814.40M

763.10M

839.32M

760.24M

750.12M

Gross Profit

2.00B

684.20

697.10M

655.50M

645.90M

628.00M

641.21M

610.33M

578.79M

Gross Profit Margin

44.0%

45.8%

43.9%

43.8%

44.2%

45.1%

43.3%

44.5%

43.6%

Total Operating Expenses

1.14B

398.30

380.60M

382.30M

380.10M

382.00M

425.06M

365.04M

359.13M

Research & Development

86.50M

28.60

28.80M

29.50M

28.20M

26.40M

27.69M

27.36M

27.03M

Selling, General & Administrative

1.05B

369.70

351.80M

352.40M

349.70M

353.80M

333.90M

335.45M

329.30M

Operating Income (EBIT)

855.80M

285.80

316.80M

271.00M

268.00M

246.00M

216.15M

245.29M

219.67M

Operating Margin

18.8%

19.1%

19.9%

18.1%

18.4%

17.7%

14.6%

17.9%

16.5%

Income Before Tax (EBT)

815.40M

273.50

304.50M

257.80M

253.10M

231.90M

197.31M

228.75M

194.89M

Interest Income

4.20M

3.10

N/A

1.80M

2.40M

1.80M

3.53M

2.43M

1.13M

Interest Expense

44.80M

15.80

15.10M

14.80M

14.90M

15.90M

17.11M

19.09M

19.67M

Other Income/Expense

-40.40M

-12.30

-12.30M

-13.20M

-14.90M

-14.10M

-18.84M

-16.55M

-24.77M

Net Income

605.00M

200.10

220.30M

192.80M

191.90M

177.40M

145.67M

173.53M

150.03M

Income Tax Expense

208.30M

72.50

84.20M

63.50M

60.60M

53.90M

50.45M

55.38M

43.51M

Net Profit Margin

13.3%

13.4%

13.9%

12.9%

13.1%

12.8%

9.8%

12.7%

11.3%

EBITDA

1.46B

285.80

677.30M

393.00M

389.70M

365.40M

338.50M

371.21M

334.92M

EBITDA Margin

32.1%

19.1%

42.6%

26.3%

26.7%

26.3%

22.9%

27.1%

25.2%

Depreciation & Amortization

604.20M

0.00

360.50M

122.00M

121.70M

119.40M

122.35M

125.91M

115.25M

EPS Basic

8.20

2.05

2.24

1.96

1.95

1.80

1.48

1.76

1.52

EPS Diluted

8.18

2.04

2.24

1.96

1.94

1.79

1.48

1.75

1.51

Shares Outstanding

98.00M

98.30M

98.40M

98.27M

98.49M

98.67M

Diluted Shares Outstanding

98.40M

98.80M

98.76M

98.94M

99.20M

Annual Report	03/31/2026	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021	03/31/2020	03/31/2019
Revenue	5.94B	5.46B	5.14B	4.54B	4.22B	3.11B	3.03B	2.78B
Cost of Goods Sold	3.31B	3.06B	2.92B	2.56B	2.34B	1.76B	1.71B	1.61B
Gross Profit	2.63B	2.40B	2.22B	1.98B	1.88B	1.34B	1.32B	1.17B
Gross Profit Margin	44.2%	44.0%	43.2%	43.7%	44.6%	43.2%	43.6%	42.2%
Total Operating Expenses	1.52B	1.54B	1.38B	1.19B	1.41B	794.73M	782.95M	763.96M
Research & Development	112.90M	107.65M	103.68M	98.48M	86.66M	66.33M	65.55M	63.04M
Selling, General & Administrative	1.41B	1.33B	1.25B	1.09B	1.32B	731.32M	716.73M	669.94M
Operating Income (EBIT)	1.10B	866.64M	836.12M	791.10M	477.81M	548.37M	537.05M	411.02M
Operating Margin	18.6%	15.9%	16.3%	17.4%	11.3%	17.6%	17.7%	14.8%
Income Before Tax (EBT)	1.05B	796.21M	702.81M	680.27M	366.80M	517.53M	498.75M	369.03M
Interest Income	9.80M	8.40M	11.04M	N/A	6.28M	6.34M	1.99M	3.02M
Interest Expense	60.70M	86.26M	144.35M	110.83M	89.49M	37.18M	40.28M	45.02M
Other Income/Expense	-54.50M	-70.43M	-133.31M	-110.83M	-111.01M	-30.84M	-38.29M	-41.99M
Net Income	785.10M	614.64M	378.24M	107.03M	243.89M	397.40M	407.66M	304.05M
Income Tax Expense	262.20M	184.65M	149.53M	124.07M	82.34M	120.66M	90.89M	64.28M
Net Profit Margin	13.2%	11.3%	7.4%	2.4%	5.8%	12.8%	13.5%	10.9%
EBITDA	1.59B	1.34B	1.40B	1.21B	1.03B	767.61M	734.28M	636.95M
EBITDA Margin	26.8%	24.6%	27.3%	26.8%	24.4%	24.7%	24.2%	22.9%
Depreciation & Amortization	486.50M	476.21M	565.24M	422.53M	553.10M	219.24M	197.24M	225.92M
EPS Basic	7.93	6.24	3.83	1.07	2.50	4.66	4.81	3.59
EPS Diluted	7.93	6.20	3.81	1.07	2.48	4.63	4.76	3.56
Shares Outstanding	98.20M	98.58M	98.79M	99.71M	97.53M	85.20M	84.78M	84.58M
Diluted Shares Outstanding	98.70M	99.07M	99.36M	100.25M	98.33M	85.90M	85.64M	85.47M

Annual Report

03/31/2026

03/31/2025

03/31/2024

03/31/2023

03/31/2022

03/31/2021

03/31/2020

03/31/2019

Revenue

5.94B

5.46B

5.14B

4.54B

4.22B

3.11B

3.03B

2.78B

Cost of Goods Sold

3.31B

3.06B

2.92B

2.56B

2.34B

1.76B

1.71B

1.61B

Gross Profit

2.63B

2.40B

2.22B

1.98B

1.88B

1.34B

1.32B

1.17B

Gross Profit Margin

44.2%

44.0%

43.2%

43.7%

44.6%

43.2%

43.6%

42.2%

Total Operating Expenses

1.52B

1.54B

1.38B

1.19B

1.41B

794.73M

782.95M

763.96M

Research & Development

112.90M

107.65M

103.68M

98.48M

86.66M

66.33M

65.55M

63.04M

Selling, General & Administrative

1.41B

1.33B

1.25B

1.09B

1.32B

731.32M

716.73M

669.94M

Operating Income (EBIT)

1.10B

866.64M

836.12M

791.10M

477.81M

548.37M

537.05M

411.02M

Operating Margin

18.6%

15.9%

16.3%

17.4%

11.3%

17.6%

17.7%

14.8%

Income Before Tax (EBT)

1.05B

796.21M

702.81M

680.27M

366.80M

517.53M

498.75M

369.03M

Interest Income

9.80M

8.40M

11.04M

N/A

6.28M

6.34M

1.99M

3.02M

Interest Expense

60.70M

86.26M

144.35M

110.83M

89.49M

37.18M

40.28M

45.02M

Other Income/Expense

-54.50M

-70.43M

-133.31M

-110.83M

-111.01M

-30.84M

-38.29M

-41.99M

Net Income

785.10M

614.64M

378.24M

107.03M

243.89M

397.40M

407.66M

304.05M

Income Tax Expense

262.20M

184.65M

149.53M

124.07M

82.34M

120.66M

90.89M

64.28M

Net Profit Margin

13.2%

11.3%

7.4%

2.4%

5.8%

12.8%

13.5%

10.9%

EBITDA

1.59B

1.34B

1.40B

1.21B

1.03B

767.61M

734.28M

636.95M

EBITDA Margin

26.8%

24.6%

27.3%

26.8%

24.4%

24.7%

24.2%

22.9%

Depreciation & Amortization

486.50M

476.21M

565.24M

422.53M

553.10M

219.24M

197.24M

225.92M

EPS Basic

7.93

6.24

3.83

1.07

2.50

4.66

4.81

3.59

EPS Diluted

7.93

6.20

3.81

1.07

2.48

4.63

4.76

3.56

Shares Outstanding

98.20M

98.58M

98.79M

99.71M

97.53M

85.20M

84.78M

84.58M

Diluted Shares Outstanding

98.70M

99.07M

99.36M

100.25M

98.33M

85.90M

85.64M

85.47M

Income Statement

Quarterly Income Statement (USD)

Annual Income Statement (USD)